Get Live Data

We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. Earnings, Trading Statements Calendar - Week Ahead

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,670.00
Bid: 1,650.00
Ask: 1,698.00
Change: 0.00 (0.00%)
Spread: 48.00 (2.909%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,670.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Earnings, Trading Statements Calendar - Week Ahead

Thu, 30th Apr 2015 05:15

UK Earnings, Trading Statements Calendar 
Thursday, April 30 
International Consolidated Airlines GroupQ1 Results
James Fisher & SonsInterim Management Statement
STV GroupInterim Management Statement
Howden JoineryInterim Management Statement
GloboFull Year Results
International Personal FinanceQ1 Interim Management Statement 
SynthomerInterim Management Statement
ShireQ1 Results at 1200 BST
SagaFull Year Results
Harvey Nash Group Full Year Results
SchrodersQ1 Interim Management Statement 
Royal Dutch ShellQ1 Results
Goldenport HoldingsFull Year Results
Moneysupermarket.comTrading Statement 
Asia Resource MineralsQ1 Results
Kaz MineralsQ1 Interim Management Statement 
Superglass HoldingsHalf Year Results
Tullow OilInterim Management Statement
Go-AheadInterim Management Statement
Lancashire HoldingsQ1 Results
Royal Bank of ScotlandQ1 Results
Smith & NephewQ1 Results
LSL Property ServicesTrading Statement 
BerendsenTrading Statement 
Friday, May 1 
Colt GroupQ1 Interim Management Statement 
Lloyds Banking GroupQ1 Interim Management Statement 
Capital & CountiesTrading Statement 
RentokilQ1 Interim Management Statement 
Monday, May 4 
No Events Scheduled  
Tuesday, May 5 
GlencoreQ1 Production Report
HSBC HoldingsQ1 Interim Management Statement 
Greene KingTrading Statement 
Aberdeen Asset ManagementHalf Year Results 
Wednesday, May 6 
CarillionInterim Management Statement
GlaxoSmithKlineQ1 Results
CRHInterim Management Statement
DS SmithTrading Statement 
Direct Line Insurance GroupQ1 Interim Management Statement
Imperial Tobacco GroupHalf Year Results 
IAGApril Traffic Statistics
Legal & General GroupQ1 Interim Management Statement 
J SainsburyFull Year Results
JD WetherspoonQ3 Interim Management Statement
Sage GroupHalf Year Results 
SupergroupQ4 Results
National ExpressQ1 Interim Management Statement
GKNInterim Management Statement 
Intu PropertiesTrading Statement 
  
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.